Association of post-treatment longitudinal symptom severity clusters with subsequent survival in oropharyngeal cancer

被引:1
|
作者
Haddad, Ghazal [1 ]
Hueniken, Katrina [2 ]
Xu, Maria Christine [3 ]
Bratman, Scott [4 ]
de Almeida, John [5 ]
Goldstein, David [5 ]
Huang, Shao Hui [3 ]
Hansen, Aaron [3 ]
Hope, Andrew [4 ]
Spreafico, Anna [3 ]
Xu, Wei [2 ]
Liu, Geoffrey [3 ,4 ,6 ,7 ,8 ]
机构
[1] Univ Toronto, Fac Med, Toronto, ON, Canada
[2] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada
[3] Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, 101 Coll St, Toronto, ON M5G0A3, Canada
[4] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[5] Univ Toronto, Univ Hlth Network, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada
[6] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada
[7] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada
[8] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
关键词
cluster analysis; head and neck neoplasms; neoplasms; oropharyngeal neoplasms; signs and symptoms; QUALITY-OF-LIFE; ASSESSMENT SYSTEM; HUMAN-PAPILLOMAVIRUS; DEPRESSIVE SYMPTOMS; HEAD; VALIDATION; DRINKING; OUTPATIENTS; SMOKING; TRENDS;
D O I
10.1002/hed.27139
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background Patients with cancer often experience multiple symptoms concurrently. We identified patient clusters based on longitudinal symptom severity trajectories in oropharyngeal cancer (OPC) and evaluated the potential clinical utility of this approach. Methods A retrospective OPC patient cluster analysis using 6 months of symptom severity data from radiotherapy initiation. The clinico-demographic characteristics and overall survival of patients were compared between clusters. Results We identified four clusters of patients differing in longitudinal symptom severity. Cluster A (n = 168) included patients with the mildest longitudinal symptoms, cluster B (n = 59) and cluster C (n = 63) were intermediate, and cluster D (n = 30) included patients with the worst symptoms. The clusters differed in their HPV status, ECOG performance status, smoking history, drinking history, treatment modality, and 5-year survival. These clusters separated symptom severity trajectories more distinctly than individual clinico-demographic characteristics. Conclusions Early symptom severity trajectory clustering revealed distinct patient clusters that were prognostic of overall survival.
引用
收藏
页码:2181 / 2196
页数:16
相关论文
共 50 条
  • [21] Family history influences post-treatment survival in patients with advanced colon cancer
    Nature Clinical Practice Oncology, 2008, 5 (9): : 501 - 501
  • [22] Family history influences post-treatment survival in patients with advanced colon cancer
    Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5 (9): : 481 - 481
  • [23] Association between post-treatment circulating biomarkers of inflammation and survival among stage II–III colorectal cancer patients
    Xinwei Hua
    Mario Kratz
    Rachel C. Malen
    James Y. Dai
    Sara Lindström
    Yingye Zheng
    Polly A. Newcomb
    British Journal of Cancer, 2021, 125 : 806 - 815
  • [24] Post-Treatment HPV Surface Brushings and Risk of Relapse in Oropharyngeal Carcinoma
    Kofler, Barbara
    Borena, Wegene
    Dudas, Jozsef
    Innerhofer, Veronika
    Dejaco, Daniel
    Steinbichler, Teresa B.
    Widmann, Gerlig
    von Laer, Dorothee
    Riechelmann, Herbert
    CANCERS, 2020, 12 (05)
  • [25] Identifying Survivors in High Need for Post-treatment Symptom Management
    Sikorskii, Alla
    Given, Charles W.
    Given, Barbara A.
    PSYCHO-ONCOLOGY, 2015, 24 : 232 - 232
  • [26] Predictors of pre- and post-treatment bowel dysfunction severity in patients with rectal cancer
    Robitaille, Stephan
    Wang, Anna
    Liberman, Sender
    Charlebois, Patrick
    Stein, Barry
    Fiore, Julio F.
    Feldman, Liane S.
    Lee, Lawrence
    SURGERY, 2023, 173 (03) : 681 - 686
  • [27] Mathematical predication models to optimize post-treatment surveillance in HPV-associated oropharyngeal cancer.
    Nair, Vivek
    Auger, Samuel
    Kochanny, Sara
    Howard, Frederick
    Ginat, Daniel
    Pasternak-Wise, Olga
    Juloori, Aditya
    Izumchenko, Evgeny
    Agrawal, Nishant
    Rosenberg, Ari
    Vokes, Everett E.
    Skandari, Reza
    Pearson, Alexander T.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [28] UTILITY OF POST-TREATMENT PET IN HPV ASSOCIATED OROPHARYNGEAL CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Lang, Pencilla
    Zayed, Sondos
    Warner, Andrew
    Boldt, Gabriel
    Mendez, Lucas
    Venkatesan, Varagur
    Sathya, Jinka
    Read, Nancy
    Palma, David
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S26 - S26
  • [29] SYMPTOM EXPERIENCES IN POST-TREATMENT CANCER SURVIVORS: RELATIONSHIPS TO MINDFULNESS AND ACCEPTANCE-BASED CONSTRUCTS
    Chinh, Kelly
    Tometich, Danielle B.
    Johns, Shelley A.
    Stutz, Patrick V.
    Mosher, Catherine E.
    ANNALS OF BEHAVIORAL MEDICINE, 2019, 53 : S512 - S512
  • [30] Post-treatment surveillance of thyroid cancer
    Wang, L. Y.
    Ganly, I.
    EJSO, 2018, 44 (03): : 357 - 366